Michael Kope
Oprichter bij Cyclarity Therapeutics, Inc.
Profiel
Michael Kope founded Cyclarity Therapeutics, Inc., where he worked as Chief Executive Officer-Corporate Affairs.
Mr. Kope also formerly worked at Aridis Pharmaceuticals, Inc., as Vice President & Corporate Development Consultant.
Mr. Kope received his graduate degree in 1990 from the University of Michigan.
Actieve functies van Michael Kope
| Bedrijven | Functie | Begin |
|---|---|---|
Cyclarity Therapeutics, Inc.
 Cyclarity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyclarity Therapeutics, Inc. provides technology to treat, cure, and reverse atherosclerosis. It develops simple and direct interventions targeting toxic forms of cholesterol using rationally designed molecules to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. The company was founded by Michael Kope and Matthew O?Connor and is headquartered in Mountain View, CA. | Oprichter | - |
Eerdere bekende functies van Michael Kope
| Bedrijven | Functie | Einde |
|---|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Michael Kope
| University of Michigan | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Cyclarity Therapeutics, Inc.
Cyclarity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyclarity Therapeutics, Inc. provides technology to treat, cure, and reverse atherosclerosis. It develops simple and direct interventions targeting toxic forms of cholesterol using rationally designed molecules to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. The company was founded by Michael Kope and Matthew O?Connor and is headquartered in Mountain View, CA. | Commercial Services |
